Also consider the timeline: if more than 28 to 30 days have passed since reconstitution, discard the vial even if it looks fine
Glucagon-like peptide-1 (GLP-1) receptor agonists are a family of antihyperglycemic drugs that have demonstrated potent HbA1c reduction, low risk of hypoglycemia, with associated weight reduction, and proven cardiovascular and renal benefits.24 In this review we describe this type of drugs, their cardiovascular and renal benefits, as well as their clinical potential in patients with DKD, especially with the new oral semaglutide formulation, now available on the market
Your healthcare provider can demonstrate optimal technique during your first visit
Patients who experience GI side effects should be advised to have frequent and smaller meals, and drink plenty of fluids to avoid dehydration
If this method was to be implemented, it would be imperative to remember the evidence to date suggests benefit only with chronic prescription of respective AOM, both in relation to weight and cardiometabolic disease
